From left, Sean Corrigan, Insight Director of Engineering, Steve McPhilliamy, Insight Partner/Director of Design, and BriteSeed co-founder Paul Fehrenbacher during a meeting at Insight Product Development in Chicago, Ill., on Thursday, March 21, 2013. | Andrew A. Nelles~Sun-Times Media
Updated: March 25, 2013 8:56AM
Paul A. Fehrenbacher and two fellow graduate students at Northwestern University are postponing their graduations to develop a technology to help surgeons identify and keep from accidentally cutting blood vessels.
Daniel Leventhal, a doctoral student in cancer biology at the University of Chicago, is helping advise two professors working to develop new ways of treating cancer with less radiation or by making radiation treatment more effective.
Both Fehrenbacher, 34, and Leventhal, 26, are benefitting from Chicago’s little-known biotech incubator, Chicago Innovation Mentors, or CIM, Sandra Guy writes at Grid.